adenosine has been researched along with Encapsulating Peritoneal Sclerosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Liu, N; Ma, X; Qiu, A; Shi, Y; Tao, M; Wang, Y; Zang, X; Zhuang, S | 1 |
Doi, S; Maeda, K; Masaki, T; Nakashima, A; Sasaki, K; Tamura, R; Ueno, T | 1 |
2 other study(ies) available for adenosine and Encapsulating Peritoneal Sclerosis
Article | Year |
---|---|
Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.
Topics: Adenosine; Animals; Apoptosis; Cell Movement; Cells, Cultured; Disease Models, Animal; Enhancer of Zeste Homolog 2 Protein; Epithelial-Mesenchymal Transition; Humans; Male; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Peritoneal Fibrosis; Peritoneum; RNA Interference; RNA, Small Interfering; Signal Transduction | 2020 |
Inhibition of the H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis.
Topics: Adenosine; Animals; Cells, Cultured; Collagen Type I; Dialysis Solutions; Epithelium; Gene Expression Regulation; Glucose; Histone Code; Histone-Lysine N-Methyltransferase; Humans; Male; Methylation; Mice; Mice, Inbred C57BL; Nitrogen; Omentum; Peritoneal Dialysis; Peritoneal Fibrosis; Promoter Regions, Genetic; Pyruvaldehyde; Transforming Growth Factor beta1 | 2018 |